Health Catalyst, Inc. (HCAT)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Health Catalyst, Inc. (HCAT) is down 43.5% since the beginning of the year. At $1 per share, HCAT is trading 68.5% below its 52-week high of $4. Investors who bought $1,000 worth of HCAT shares 5 years ago would now be looking at an investment worth $26.

Health Catalyst, Inc. (HCAT) has returned -43.51% so far this year and -64.38% over the past 12 months.

Based on dividend-adjusted daily data since Jul 25, 2019, HCAT's average daily return is -0.11%, while the average monthly return is -2.93%.

Historically, 37% of months were positive and 63% were negative. The best month was Jan 2023 with a return of +30.8%, while the worst month was Apr 2022 at -36.3%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 10 months.

On a daily basis, HCAT closed higher 47% of trading days. The best single day was Aug 8, 2024 with a return of +37.8%, while the worst single day was Aug 5, 2022 at -37.9%.

Health Catalyst, Inc. has an annualized alpha of -37.63%, beta of 1.26, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since July 26, 2019.

• This stock participated in 207.93% of S&P 500 Index downside but only 19.82% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.15 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

HCAT ranks 8 for risk / return — in the bottom 8% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for Health Catalyst, Inc. (HCAT) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Health Catalyst, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Health Catalyst, Inc. was 98.30%, occurring on Apr 10, 2026. The portfolio has not yet recovered.

The current Health Catalyst, Inc. drawdown is 97.70%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Health Catalyst, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Health Catalyst, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.